Summary of Bill S 1619: Allows a Licensed Pharmacist to Order and Administer Certain Tests

Purpose and Intent

Bill S 1619 aims to expand the role of licensed pharmacists by granting them the authority to order and administer specific medical tests. This legislative measure is designed to enhance healthcare accessibility and efficiency, particularly in community settings where pharmacists can serve as accessible healthcare providers.

Key Provisions

• Authority Granted: The bill specifically allows licensed pharmacists to order and administer certain diagnostic tests. The types of tests that may be included are not detailed in the provided information but typically encompass common health screenings such as blood glucose, cholesterol, and other point-of-care tests.

• Regulatory Framework: The bill likely establishes guidelines and protocols for pharmacists to follow when ordering and administering these tests, ensuring that they operate within a safe and effective framework.

• Training Requirements: While not explicitly mentioned, it is common for such legislation to include provisions for training and certification to ensure pharmacists are adequately prepared to perform these tasks.

Who Would Be Affected

• Pharmacists: Licensed pharmacists will gain additional responsibilities and capabilities, allowing them to play a more active role in patient care.

• Patients: Individuals seeking healthcare services may benefit from increased access to testing, particularly in underserved areas where healthcare providers are limited. This could lead to quicker diagnoses and treatment plans.

• Healthcare System: The bill may alleviate some pressure on primary care providers by allowing pharmacists to handle certain tests, potentially leading to more efficient use of healthcare resources.

Legislative Timeline

• Introduced: January 13, 2025
• Referred to Health Committee: January 13, 2025
• Advanced to Third Reading: January 27, 2025
• Passed Senate: March 10, 2025
• Delivered to Assembly: March 10, 2025
• Referred to Higher Education: March 10, 2025

Related Bills

This bill is connected to several prior-session bills that may have similar intents or provisions:
- A 11256
- S 5092
- S 2529
- S 3467
- A 3285 (companion bill)

Conclusion

Bill S 1619 represents a significant step towards empowering pharmacists in the healthcare system, potentially improving patient access to necessary diagnostic tests. As it progresses through the legislative process, further details regarding the specific tests and training requirements may be clarified. The bill's passage could mark a pivotal change in how healthcare services are delivered at the community level.